Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:
methylphenidate_old
methylphenidate_old
- Formulary Methylphenidate Formulary
- Restricted Daytrana --> restricted to continuation of therapy
| Drug Name | Form | Strength | Formulary Unrestricted | Formulary Restricted | Non-Formulary | Interchange |
|---|---|---|---|---|---|---|
| Aptensio XR | CAPSULE, EXTENDED RELEASE, ORAL | 10 mg, 15 mg, 20 mg , 30 mg, 40 mg, 50 mg, 60 mg | ||||
| Metadate CD | CAPSULE, EXTENDED RELEASE, ORAL | 10 mg | ||||
| Ritalin LA | CAPSULE, EXTENDED RELEASE, ORAL | 20 mg, 30 mg | ||||
| Daytrana | FILM, EXTENDED RELEASE, TRANSDERMAL | 10 mg, 15 mg, 20 mg, 30 mg | ||||
| Quillivant XR | SUSPENSION, ORAL | 5 mg/mL | ||||
| QuilliChew ER | TABLET, CHEWABLE, EXTENDED RELEASE, ORAL | 20 mg, 30 mg, 40 mg | ||||
| Methylin | TABLET, CHEWABLE, ORAL | 2.5 mg, 5 mg, 10 mg | ||||
| Cotempla XR-ODT | TABLET, DISINTEGRATING, EXTENDED RELEASE, ORAL | 8.6 mg, 17.3 mg, 25.9 mg | ||||
| Concerta | TABLET, EXTENDED RELEASE, ORAL | 18 mg, 27 mg | ||||
| Metadate ER, Ritalin-SR, Methylin ER | TABLET, EXTENDED RELEASE, ORAL | 20 mg | ||||
| Concerta | TABLET, EXTENDED RELEASE, ORAL | 36 mg, 54 mg | ||||
| Ritalin | TABLET, ORAL | 5 mg, 10 mg, 20 mg |
Last updated: Sep. 30, 2019
- Black Box Warning: Tolerance and dependence
- Formulary, Not Routinely Stocked: Daytrana --> 10 mg, 15 mg, 20 mg, 30 mg
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
NOTES
methylphenidate (Aptensio XR)
methylphenidate (Metadate CD)
Give at same dosing interval.
methylphenidate (Aptensio XR)
methylphenidate (Ritalin LA)
Give at same dosing interval.
methylphenidate (Cotempla XR-ODT)
methylphenidate
methylphenidate (Methylin)
methylphenidate (Ritalin)
Give at same dosing interval.
methylphenidate ER (QuilliChew ER)
methylphenidate ER (Ritalin LA)
Give at same dosing interval.
Concerta medication guide
Daytrana medication guide
Metadate CD medicaiton guide
Methylin chewable tablet medication guide
Methylin oral solution medication guide
QuilliChew ER medication guide
Quillivant XR medication guide
Ritalin medication guide
Ritalin LA medication guide
Ritalin-SR medication guide
Daytrana (methylphenidate patch) is approved for formulary if a patient already on the patch needs to continue therapy in the hospital and doesn't have their own. Initiation should be deferred to the outpatient setting, and if possible the patient should use their home medication for inpatient use. If this is not possible, a small number of patches may be ordered.
QUILLAVANT XR is classified as non-formulary, not stocked. Contact the prescriber to switch to an alternative methylphenidate product; or if necessary, the patient may use his/her own supply during admission.
Reviewed: July 25, 2006 (DAYTRANA), and March 26, 2013 (Quillivant XR), and 17 Nov 2015 (Aptensio XR), and 26 July 2016 (QuilliChew ER), and 24 Oct 2017 (Cotempla XR)